HIV Care in a Post-COVID-19 World — eHIV Review Educational Series Receives Eighth Installation

HIV Care in a Post-COVID-19 World — eHIV Review Educational Series Receives Eighth Installation
Contact: Matt Miller
Phone: 646-336-6495
Fax: 646-336-6497
Email: [email protected]

NEW YORK (2/27/2023) – DKBmed, LLC, is renewing its popular eHIV Review series for an eighth volume. This latest installment provides clinicians with best practices in HIV care in the aftermath of the COVID-19 pandemic. Like the previous edition, each journal brief features an expert guest author who reviews the latest clinical data and literature on an HIV subtopic; companion podcast/webcast episodes provide a platform for the guest authors, to discuss the implications of advancements in HIV care on routine clinical practice. In addition, this volume features interviews with people living with HIV who share their real-world experiences with the health care system.

Continuation of the long-running eHIV review series comes after the resounding success of the seventh volume, which exceeded its learner enrollment target by 43%.

The disruption caused by the COVID-19 pandemic over the last three years has reversed progress by healthcare systems to extinguish the HIV epidemic. In its Ending the HIV Epidemic Initiative, the U.S. Department of Health and Human Services (HHS) aimed to reduce the number of new, domestic HIV diagnoses by 75% between 2019 and 2024 and by 90% by the end of the decade. Additionally, HHS hoped to ensure that at least 95% of Americans with HIV receive a diagnosis and over half of those at risk for acquiring HIV receive pre-exposure prophylaxis (PrEP) treatment. Instead, while clinics were shut for all but essential services, PrEP prescriptions declined by 21% and new PrEP users declined by 28%. During the first six months of COVID-19 pandemic, 700,000 fewer HIV screening tests were performed and 5,000 fewer HIV diagnoses were made.

“Findings from an observational study published in Lancet Regional Health suggest that there is a population of patients in the U.S. who are newly infected with HIV but not yet identified because of COVID-19-linked disruptions to healthcare systems,” notes Justin Alves, RN, ACRN, CARN a Nurse Educator at Boston Medical Center. “Although HIV testing and PrEP prescription rates rebounded pretty robustly into 2021,2 there is a need for augmented efforts to identify ‘missed’ patients and link them to HIV services. Programs, such as the eHIV review, can help get us back on track and put an end to the HIV epidemic.”

The program can be found at

Volume 8 of eHIV Review will address the following acknowledged gaps in clinician education:

  • Stigma and social barriers that lead to disparities in HIV prevention
  • Inadequate testing for HIV in youth, young adult populations
  • Awareness of mental health needs of members in the LGBTQ community, people living with HIV
  • Familiarity with newer and emerging options for treating HIV (antiretrovirals) and preventing HIV (PrEP)
  • The appropriateness of including an NNRTI in the ART regimen for certain patients
  • Strategies that improve testing, PrEP, and HIV treatment in cisgender and transgender women

eHIV Review is one component of the highly successful and popular eLiterature Review series published through DKBmed’s collaboration with the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing. Each installment consists of a newsletter and podcast. To view this and similar learning programs centered on other conditions, including cystic fibrosis, HIV, and COPD, visit

Credit Designation Statements

eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material – Internet activity for a maximum 6.0 AMA PRA Category 1 CreditsTM (1 AMA PRA Category 1 CreditTM per monthly review). Physicians should only claim credit commensurate to the extent of their participation in the activity.
Podcast: The Johns Hopkins University School of Medicine designates this enduring material – Internet activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM.

eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6.0 contact hours for the 6 newsletters in this program. Podcast: These paired, 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3.0 contact hours for the 6 podcasts in the program.

Disclosure of Support

Volume 8 of eHIV review is supported by educational grants provided by Gilead Sciences, Inc., Merck & Co., and ViiV Healthcare.

About DKBmed

DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

Working with accredited providers and other partners, DKBmed develops innovative educational programs and quality improvement (QI) initiatives, bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in Pain Management, HIV, Depression, Influenza, and Diabetic Eye Disease. DKBmed was also an early adopter of case scenarios with real patients and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, and smart phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn and access educational programs in a manner that is most convenient and appropriate for them.

DKBmed’s programs are accessible through the company’s website ( They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.